Skip to main content
Home/Peptides/BPC-157
HEALING PEPTIDE
FDA-Approved

BPC-157

Body Protection Compound-157

Synthetic 15-amino-acid peptide derived from human gastric juice, studied for tissue repair and gut healing.

Regulatory status last verified 2026-04-24
FDA STATUS
Not FDA-approved
HALF-LIFE
30–60 minutes (systemic), with extended local tissue half-life
ROUTE
Subcutaneous or intramuscular
CLASSIFICATION
Synthetic pentadecapeptide
AMINO ACID SEQUENCE

15 residues· First described 1991

Hydrophobic
Acidic (-)
Basic (+)
Special
USED IN PROTOCOLS FOR
Recover FasterSkin & AestheticsGut HealthImmunity

Overview

BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein found in human gastric juice. It has been studied in preclinical research for its effects on tissue repair, angiogenesis (new blood vessel formation), and gut lining integrity. BPC-157 is one of the most widely used healing peptides in the optimization community due to its stability at room temperature and accessibility through 503A compounding pharmacies following the 2026 reclassification.

Unlike many peptide therapies that target a single receptor, BPC-157 operates across multiple repair pathways simultaneously - nitric oxide regulation, VEGF signaling for new blood vessel growth, dopamine modulation, and direct action on gut mucosa. This multi-pathway effect is what makes it a foundational compound in tissue-repair stacks like the "Wolverine Stack" (BPC-157 + TB-500) and post-surgical recovery protocols.

Tracking compounds like BPC-157 requires context - logging injection sites, dose timing, and corresponding biomarker trends (inflammation markers, CBC) lets users see how the compound performs for their specific protocol rather than relying on general community anecdote.

Mechanism of Action

BPC-157 is believed to act via upregulation of growth hormone receptors at injury sites, stimulation of nitric oxide synthesis, and activation of angiogenic pathways including VEGF. It protects the endothelium, supports gut epithelial repair, and has been shown in animal studies to accelerate healing of tendon, ligament, muscle, and soft tissue injuries. The compound also interacts with the dopaminergic system, which may explain anti-inflammatory and mood-stabilizing effects reported by some users.

Community Usage Patterns

Community users typically run BPC-157 at 250–500 mcg per dose, 1–2 times daily. For localized injuries, subcutaneous injection near the affected area is common. For systemic use (gut healing, anti-inflammatory effects), abdominal subcutaneous injection is standard. Cycles typically run 4–12 weeks. BPC-157 is often stacked with TB-500 for connective-tissue repair or GHK-Cu for skin and wound-healing protocols.

Education only - not medical advice. Any protocol change should involve your licensed provider.

Biomarkers to Track

When running BPC-157, these are the biomarkers most commonly tracked to assess response and safety:

hs-CRP (inflammation)CBC with differentialFerritinIGF-1 (when stacked)

Reconstitution Calculator

Free calculator for BPC-157 reconstitution math - vial size, BAC water volume, and exact syringe units.

Open BPC-157 calculator →

Related Reading

Related Peptides

TB-500
Healing
GHK-Cu
Cosmetic

Stacks That Include BPC-157

RECOVERY STACK
Wolverine Recovery Stack
The most-researched soft-tissue repair combination - BPC-157 anchored with TB-500 for systemic cellular migration.
AESTHETIC STACK
Glow Stack
GHK-Cu + Epithalon + BPC-157 - the skin, collagen, and cellular-aging combination users research for aesthetic outcomes.
LONGEVITY STACK
Longevity Core Stack
Epithalon + BPC-157 + GHK-Cu - the foundational long-cycle combination users research for cellular aging and systemic repair.
RECOVERY STACK
Injury Rehabilitation Stack
BPC-157 + TB-500 + Thymosin Beta-4 - the expanded tissue-repair combination for post-surgical and chronic-injury research.

BPC-157 Head-to-Head Comparisons

BPC-157 vs TB-500
Users researching soft-tissue injury protocols, post-surgical recovery, or chronic tendinopathy.
GHK-Cu vs BPC-157
Users building healing + aesthetic protocols.

Conditions BPC-157 is Commonly Researched For

Informational only - BPC-157 is not presented as a treatment for any condition below. These are contexts in which users research the compound and discuss it with their licensed provider.
INFLAMMATION
Chronic Low-Grade Inflammation
The persistent low-level inflammatory pattern linked to cardiovascular, metabolic, and cognitive disease - trackable via specific markers.
RECOVERY
Poor Recovery / Overtraining
The pattern users see when training load exceeds recovery capacity - trackable via HRV, RHR, and specific biomarkers.
Track BPC-157 against your labs.

Log doses, upload your lab PDFs, and let StackAI read your panel in context of what you're actually running. Free to start.

Start tracking →

This page is informational and does not constitute medical advice. MyProtocolStack is a tracking and education platform. Work with a licensed provider before starting, changing, or stopping any protocol.